AML-MRC e mutazione FLT3: quale gerarchia nella scelta terapeutica?
- Published in:
- Current Therapeutics, 2022, v. 25, n. 8, p. 8
- By:
- Publication type:
- Article
Works matching IS 20350236 AND DT 2022 AND VI 25 AND IP 8
Results: 2
1
2
Efficacia protratta e mielosoppressione prolungata: due facce della stessa medaglia.
- Published in:
- Current Therapeutics, 2022, v. 25, n. 8, p. 3
- By:
- Publication type:
- Article